GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital solutions provider. Its products, services, and solutions enable clinicians to make informed decisions, improving patient care from diagnosis to the…
Medical - Healthcare Information Services
US, Chicago [HQ]
Ratios
5 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross Margin | 39.37 | 39.43 | 40.80 | 39.14 | 40.52 | |
| Profit Margin | 9.16 | 11.99 | 12.78 | 10.45 | 8.02 | |
| Operating Margin | 12.77 | 15.85 | 15.89 | 13.75 | 12.45 | |
|
EPS Growth
|
- - | 35.22 | 8.17 | -13.88 | -27.96 | |
| EPS USD | 335.00 | 453.00 | 490.00 | 422.00 | 304.00 | |
| Return on Assets (ROA) | - - | 8.49 | 8.54 | 6.96 | 4.83 | |
| Return on Equity (ROE) | - - | 13.97 | 13.49 | 20.48 | 21.98 | |
| Return on Invested Capital (ROIC) | - - | 13.59 | 12.94 | 11.11 | 9.82 | |
| Solvency | ||||||
| Equity Ratio | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 1.93 | 1.66 | 29.95 | 30.39 | |
| Debt/Equity | - - | 3.18 | 2.62 | 88.16 | 138.27 | |
| Debt/EBITDA | - - | -15.44 | -3.31 | 211.17 | 209.76 | |
|
Debt/Capitalization
|
- - | 3.08 | 2.56 | 46.85 | 58.03 | |
| Long-Term Debt/Capitalization | - - | 2.23 | 1.93 | 46.81 | 55.08 | |
| Interest Debt per Share USD | 0.19 | 1.17 | 1.05 | 18.34 | 22.87 | |
| Debt Growth | - - | - - | -6.62 | 1,787.64 | 19.57 | |
| Liquidity | ||||||
| Current Ratio | - - | 90.37 | 103.53 | 115.67 | 104.78 | |
| Quick Ratio | - - | 55.96 | 64.27 | 79.91 | 75.14 | |
| Cash Ratio | - - | 15.24 | 8.19 | 20.09 | 27.77 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | |
| Turnover | ||||||
| Inventory Turnover | - - | 652.26 | 535.00 | 517.96 | 593.37 | |
| Receivables Turnover | - - | 645.99 | 463.86 | 426.44 | 459.61 | |
| Payables Turnover | - - | 480.90 | 409.88 | 379.14 | 394.64 | |
|
Asset Turnover
|
- - | 70.84 | 66.84 | 66.60 | 60.25 | |
| Fixed Turnover | - - | 779.47 | 786.80 | 792.61 | 782.08 | |
| Coverage | ||||||
| Interest Coverage | 2,413.64 | 4,121.21 | 6,987.50 | 3,275.32 | 449.26 | |
| Asset Coverage | - - | 3,400 | 4,000 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | - - | 360.47 | 367.73 | 25.62 | 21.30 | |
| EBITDA Coverage | 3,200 | 5,100 | 8,800 | 4,100 | 600 | |
| Dividend Coverage | - - | - - | - - | - - | -3,800 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||
| Dividend Yield | - - | - - | - - | - - | 0.12 | |
| Earnings Yield | 5.59 | 7.54 | 8.24 | 7.23 | 4.46 | |
|
Price/Earnings (P/E)
|
1,790.20 | 1,325.69 | 1,214.18 | 1,383.10 | 2,243.66 | |
| Price/Earnings Growth (PEG) | - - | 37.64 | 148.65 | -99.66 | -80.24 | |
|
Price/Book (P/B)
|
- - | 185.26 | 163.81 | 283.21 | 493.21 | |
| Price/Tangible Book (P/TB) | - - | 185.26 | 163.81 | 283.21 | 493.21 | |
| Price/Sales (P/S) | 164.03 | 158.95 | 155.15 | 144.49 | 179.93 | |
|
Price/Cash Flow (P/CF)
|
1,371.67 | 1,617.23 | 1,697.73 | 1,254.15 | 1,674.47 | |
| Price/Free CF (P/FCF) | 1,645.51 | 1,910.55 | 2,007.55 | 1,469.78 | 2,052.54 | |
| Price/Operating CF (P/OCF) | 1,371.67 | 1,617.23 | 1,697.73 | 1,254.15 | 1,674.47 |